• Ichiro Yoshino, Masafumi Yamaguchi, Tatsuro Okamoto, Chie Ushijima, Yasuro Fukuyama, Yukito Ichinose, and Yoshihiko Maehara.
• Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. iyoshino@surg2.med.kyushu-u.ac.jp
• World J Surg Oncol. 2004 Jan 1; 2: 11.

BackgroundMalignant pleural mesothelioma is a rare malignancy. The outcome remains poor despite complete surgical resection.Patients And MethodsEleven patients with histologicaly proven epithelial type malignant pleural mesothelioma undergoing extrapleural pneumonectomy with systemic chemotherapy and/or radiotherapy before and after surgical resection were retrospectively reviewed.ResultsTen out of 11 patients underwent complete surgical resection, of these 7 patients had stage I disease. Of these 7 patients, 5 are alive without any recurrence, a 2-year survival rate of 80% was observed in this group. There was no operative mortality or morbidity.ConclusionExtrapleural pneumonectomy with perioperative adjuvant treatment is safe and effective procedure for epithelial type malignant pleural mesothelioma.

9 keywords...

hide…